Send to:

Choose Destination
See comment in PubMed Commons below
J Med Ethics. 2005 Dec;31(12):733-5.

Can artificial parthenogenesis sidestep ethical pitfalls in human therapeutic cloning? An historical perspective.

Author information

  • 1Institute for the History of Medicine, Heinrich-Heine University Düsseldorf, Universitaetsstrasse 1, 40225 Düsseldorf, Germany.


The aim of regenerative medicine is to reconstruct tissue that has been lost or pathologically altered. Therapeutic cloning seems to offer a method of achieving this aim; however, the ethical debate surrounding human therapeutic cloning is highly controversial. Artificial parthenogenesis-obtaining embryos from unfertilised eggs-seems to offer a way to sidestep these ethical pitfalls. Jacques Loeb (1859-1924), the founding father of artificial parthenogenesis, faced negative public opinion when he published his research in 1899. His research, the public's response to his findings, and his ethical foundations serve as an historical argument both for the communication of science and compromise in biological research.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk